Publications by authors named "Marco Tucci"

Claim this Profile
H
High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Michele Guida, Benedetta Apollonio, Luca Romano, Francesco Spagnolo, Pietro Quaglino, Marco Tucci

J Transl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.
Mario Mandalà, Teresa Amaral, Piotr Rutkowski, Maria Chiara Sergi, Marie-Lena Rasch, Marco Tucci

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in Advanced Cutaneous Melanoma: From the Optimal Treatment Duration to the Impact on Survival in Case of Early Discontinuation Due to Immune-Related Adverse Events.
Giacomo Triggiano, Gaetano Pezzicoli, Marco Tucci

Biomolecules· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP-MADAM (Maximing ADjuvAnt MAP): Interim Analysis.
Francesca Consoli, Marco Tucci, Jacopo Pigozzo, Ester Simeone, Francesco Spagnolo

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma.
Paolo A Ascierto, Mario Mandalà, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Rutkowski, Marco Tucci

NEJM Evid· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes.
Patrizia Leone, Eleonora Malerba, Marcella Prete, Antonio Giovanni Solimando, Giorgio Alberto Croci, Marco Tucci

Biomark Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.
Mario Mandalà, Paul Lorigan, Maria Chiara Sergi, Naima Benannoune, Patricio Serra, Marco Tucci

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
Alessandro Parisi, Blandine Delaunay, Giada Pinterpe, Antoine Hollebecque, Jean Frederic Blanc, Marco Tucci

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
Paolo A Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Marco Tucci

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.
Bruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, Sarah Orlando, Davide Romandini, Marco Tucci

Ther Adv Med Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients with -mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib.
Massimo Aglietta, Vanna Chiarion-Sileni, Paolo Fava, Massimo Guidoboni, Roberta Depenni, Marco Tucci

Tumori· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Melissa Bersanelli, Alessio Cortellini, Alessandro Leonetti, Alessandro Parisi, Marcello Tiseo, Marco Tucci, Luigia Stefania Stucci

Cancer Immunol Immunother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment.
Maria Chiara Sergi, Elisabetta Filoni, Giacomo Triggiano, Gerardo Cazzato, Valeria Internò, Marco Tucci

Curr Oncol Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Real-World Patients with High-Risk -Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.
Pietro Quaglino, Paolo A Ascierto, Francesca Consoli, Paola Queirolo, Francesco Spagnolo, Marco Tucci

Cancer Manag Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide arrests cell cycle and modulates PD1-dependent downstream mTOR intracellular signals in melanoma cells.
Claudia Felici, Anna Passarelli, Paola Cafforio, Vito Racanelli, Patrizia Leone, Marco Tucci

Melanoma Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.
Luca Cantini, Francesco Paoloni, Federica Pecci, Francesco Spagnolo, Carlo Genova, Marco Tucci

J Natl Cancer Inst· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Marco Rubatto, Paolo Fava, Ignazio Stanganelli, Simone Ribero, Jacopo Pigozzo, Marco Tucci

Eur J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary, Sebastiano Buti, Melissa Bersanelli, Marco Tucci, Luigia Stefania Stucci

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on Merkel cell carcinoma.
Maria Chiara Sergi, Eleonora Lauricella, Camillo Porta, Marco Tucci, Mauro Cives

Biochim Biophys Acta Rev Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Inhibitor-Induced Colitis: An Update.
Giuseppe Losurdo, Daniele Angelillo, Nicolas Favia, Maria Chiara Sergi, Alfredo Di Leo, Marco Tucci

Biomedicines· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies.
Valeria Internò, Maria Chiara Sergi, Maria Elvira Metta, Michele Guida, Paolo Trerotoli, Marco Tucci

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial.
Paolo A Ascierto, Mario Mandalà, Pier Francesso Ferrucci, Massimo Guidoboni, Piotr Rutkowski, Marco Tucci

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.
Alessio Cortellini, Gino M Dettorre, Urania Dafni, Juan Aguilar-Company, Luis Castelo-Branco, Marco Tucci

J Immunother Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report.
Joanna Placzke, Paweł Teterycz, Pietro Quaglino, Bozena Cybulska-Stopa, Marco Tucci

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study.
Riccardo Marconcini, Paolo Fava, Amedeo Nuzzo, Simona Manacorda, Marco Ferrari, Marco Tucci

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis